Allan L. Goldstein, Ph.D., Professor Emeritus in Residence of Biochemistry and Molecular Medicine, co-authored a paper published in Nature Medicine finding a potential new drug to treat and stop the progression of cystic fibrosis.
Researchers at the GW School of Medicine and Health Sciences found a majority of first-year medical students changed their online behavior after participating in a social media and professionalism course, with results published in the Teaching and Learning in Medicine journal.
Fourth-year medical students at the GW School of Medicine and Health Sciences will gather with family, friends, alumni, and faculty for a Match Day ceremony on Friday, March 17.
Researchers at the George Washington University (GW) have developed a way to test recombinant vaccines for their ability to stay effective after years of storage. This is an important next step in the development of a recombinant hookworm vaccine being developed at GW.
Mitchell R. Smith, M.D., Ph.D., has been appointed as the associate center director for clinical investigations at the GW Cancer Center. In this role, Smith will be responsible for overseeing all clinical cancer research and the clinical cancer research infrastructure of the GW Cancer Center.
Clinicians and researchers from the GW Department of Dermatology will present on a variety of topics, including nanotechnology, fungal infections of the skin, cannabis for autoimmune diseases, contact dermatitis, and public health threats at the 75th Annual Meeting of the American Academy of Dermatology.
GW and the U.S. Food and Drug Administration will hold a workshop, “High-Throughput Sequencing Computational Standards for Regulatory Sciences,” March 16-17, 2017 in Bethesda, Maryland.
Mandi Pratt-Chapman, M.A., associate center director for patient-centered initiatives and health equity at the GW Cancer Center, co-authored a commentary published in The Lancet Oncology, which calls to bridge the gap between the achievable and the accessible in cancer care.